Compound medicine for treating gastrointestinal tumor

Abstract

The invention discloses a compound medicine for treating gastrointestinal tumor. The compound medicine is prepared from the following traditional Chinese medicine raw materials in parts by weight: 5-10 parts of water chestnut hull, 5-8 parts of dindygulen peperomia herb, 5-8 parts of solanum dulcamara, 5-8 parts of isodon japonica var.galaucocalyx, 3-8 parts of herb of pilosella-leaved drymoglossum, 5-8 parts of aeschynanthus acuminatus wall, 3-5 parts of Chinese actinidia root, 5-8 parts of herba selaginellae doederleinii, 3-5 parts of herba lagotis, 8-10 parts of cortex albiziae, 2-5 parts of prunella vulgaris, 2-4 parts of radix scutellariae, 2-4 parts of cortex phellodendri, 2-4 parts of fructus forsythiae, 2-4 parts of dandelion, 2-5 parts of Indian iphigenia bulb, 3-5 parts of herba patriniae, 2-3 parts of longstamen onion bulb, 5-8 parts of circium japonicum, 3-5 parts of algae and 3-5 parts of kelp. According to the theory that the traditional Chinese medicine has the functions of reinforcing healthy qi and consolidating root and activating blood and resolving stasis, the compound medicine has the functions of tonifying liver and kidney, replenishing qi and nourishing yin, clearing heat and removing toxin and dissipating and eliminating swelling; and when being used for treating gastrointestinal tumor, the compound medicine treats both symptoms and root causes, realizes a good curative effect and takes effect quickly.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, in particular to a compound medicine for treating gastrointestinal tumors. Background technique [0002] Gastrointestinal tumors are benign and malignant tumors that occur in the stomach, small intestine, and large intestine. Clinical manifestations vary according to the nature and location of tumor occurrence. In general, benign tumors can be asymptomatic or have very mild symptoms. Some malignant tumors have no obvious symptoms in the early stage, which affects diagnosis, treatment and prognosis. Among gastrointestinal tumors, the incidence of tumors in the small intestine is lower than that in the esophagus, stomach, and large intestine. [0003] Manifested as severe abdominal pain, intestinal bleeding, intestinal obstruction, abdominal mass and weight loss. The symptoms of malignant tumors are more and more severe, while the symptoms of benign tumors are mild or asymp...

AI Technical Summary

Problems solved by technology

In addition to conventional chemotherapy drugs, humanized antibody drugs, molecular targeted drugs, and new targeted carrier drugs are all very expensive